ReviewDermatology and therapy2026
Podcast: Adherence to Injectables.
Review in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with chronic illnesses, especially those with autoimmune conditions such as rheumatoid arthritis, chronic urticaria, Crohn's disease, psoriasis, and diabetes, rely on injectable therapies for disease management. However, it is well established that patients with chronic illnesses often have poor adherence to therapy, with adherence rates reported to be approximately 50%. This leads to issues with gauging treatment efficacy, potentially leading to worsening of their disease, thus more appointments with healthcare professionals (HCPs), and consequently a higher cost burden placed on healthcare systems. Hence, there is an unmet need to educate HCPs on the topic of supporting patients to optimize the use of injectable therapies. In this podcast, Professor Jorge Sánchez of the University of Antioquia, Medellín, Colombia, brings awareness to some of the key causes of non-adherence to injectable therapy, explains how to identify patients who are at high risk for non-adherence, and discusses how issues with the use of injectables can be managed or improved to increase adherence. The podcast also highlights some patient-focused means of improving treatment adherence, such as providing patient counseling, education, and practice administration sessions to help with patient confidence and empowerment. In conclusion, there is a need for HCPs to identify and improve poor adherence to injectable therapies among patients with chronic illnesses. Podcast video (MP4 157107 KB).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.